Clinical Trial Update: Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia [Phase 3]

View source ↗

Summary

Phase 3 study comparing recombinant antithrombin to placebo in preterm preeclampsia completed; results on pharmacokinetics, safety and efficacy have been posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia

Drugs mentioned

• Recombinant Antithrombin (recombinant human antithrombin III)

Snippet

Sponsor: rEVO Biologics | Conditions: Preeclampsia | Phase 3 | Status: COMPLETED | Results posted: 2017-08-09